Table 1.

Clinical data on patients with AS, RA and OA

Diagnosis	Patient No.	Sex	Age (years)	HLA-B27	RF	anti-CCP U/ml	ESR (mm.h-1)	CRP (mg.dL-1)	Disease duration (years)	NSAIDs	DMARDs
AS	1	male	35	+	-	-	46	34	3	yes	yes
AS	2	male	29	+	-	-	7	6	12	yes	yes
AS	3	male	24	+	-	-	16	6	5	yes	yes
AS	4	male	31	+	-	-	45	6	6	yes	yes
AS	5	male	36	+	-	-	40	6	6	yes	yes
AS	6	male	37	+	-	-	24	5	8	yes	yes
AS	7	male	13	+	-	-	62	8	7	yes	yes
AS	8	female	48	+	-	-	58	10	5	yes	yes
AS	9	female	28	+	-	-	10	6	10	yes	yes
AS	10	female	54	+	-	-	12	6	10	yes	yes
RA	11	female	30	ND	100	209	80	6	4	yes	yes
RA	12	female	58	ND	160	279	72	192	9	yes	yes
RA	13	female	65	ND	496	218	66	153	7	yes	yes
RA	14	female	41	ND	78	168	39	10	3	yes	yes
RA	15	female	64	ND	200	169	61	10	5	yes	yes
RA	16	male	53	ND	107	171	55	20	3	yes	yes
RA	17	female	49	ND	160	227	50	96	4	yes	yes
RA	18	male	50	ND	1280	394	84	153	6	yes	yes
RA	19	female	53	ND	599	171	31	6	7	yes	yes
RA	20	female	48	ND	107	92	13	60	10	yes	yes
OA	21	male	40	ND	-	ND	10	6	6	yes	-
OA	22	female	62	ND	-	ND	68	48	10	yes	-
OA	23	female	53	ND	-	ND	20	6	8	yes	-
OA	24	female	60	ND	-	ND	22	6	8	yes	-
OA	25	male	66	ND	-	ND	24	10	6	yes	-
OA	26	female	72	ND	-	ND	24	6	5	yes	-
OA	27	male	65	ND	-	ND	5	10	11	yes	-
OA	28	male	72	ND	-	ND	8	6	13	yes	-
OA	29	male	68	ND	-	ND	24	6	7	yes	-
OA	30	male	67	ND	-	ND	10	20	6	yes	-

ND: no data available